(Q38221769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Interventional therapies for malignant pleural effusions: the present and the future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Rajesh Thomas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Helen E Davies

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Y C Gary Lee

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

19 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

809-822

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947955%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the cancer incidence and mortality in Europe in 2006.

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Management of malignant pleural effusions: questions that need answers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleurodesis outcome in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Plasma and pleural fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small-cell lung cancer with pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Ultrasound-guided thoracentesis: is it a safer method?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Thoracotomy and thoracoscopy: postoperative pulmonary function, pain and chest wall complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

The impact of thoracoscopy on the management of pleural disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

The evidence on the effectiveness of management for malignant pleural effusion: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleurodesis for malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Systemic distribution of talc after intrapleural administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleurodesis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Alternative widely available, inexpensive agents for pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Symptom management in patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

BTS guidelines for the management of malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Management of malignant pleural effusion associated with trapped lung syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Rapid pleurodesis for malignant pleural effusions: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Catheter tract metastasis associated with indwelling pleural catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Pleuro-peritoneal shunting. Alternative therapy for pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Malignant pleural effusions: fixing the leaky faucet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Malignant pleural effusion: tumor-host interactions unleashed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Zoledronic acid is effective against experimental malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12328